Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity.
Alina Yu BabenkoDaria A SavitskayaYulia A KononovaAleksandra Yu TrofimovaAnna V SimanenkovaElena Yu VasilyevaEvgeny V ShlyakhtoPublished in: Journal of diabetes research (2019)
The evaluation of the glycemic control, lipid profile, and GLP-1, GIP, and ghrelin levels are useable for estimating the expected efficacy of aGLP-1.